Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 18 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Frontieras North America Inc. Advancing FASForm(TM) for Domestic, Feedstock-Driven Energy Production
Frontieras is positioned amid increased demand for domesticenergy production. “At the core of its strategy is…
-
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Expands Gold Asset Portfolio in Abitibi Supporting Mine-to-Mill Platform
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid…
-
American Fusion(TM) Inc. (AMFN) Expands into Government Procurement While Advancing Fusion Energy Development
American Fusion(TM) launched a Government Procurement Services segment alongside its fusion energy development business. The…